Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Evis Havari"'
Autor:
Ross C. Gruber, Gregory S. Wirak, Anna S. Blazier, Lan Lee, Michael R. Dufault, Nellwyn Hagan, Nathalie Chretien, Michael LaMorte, Timothy R. Hammond, Agnes Cheong, Sean K. Ryan, Andrew Macklin, Mindy Zhang, Nilesh Pande, Evis Havari, Timothy J. Turner, Anthony Chomyk, Emilie Christie, Bruce D. Trapp, Dimitry Ofengeim
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Neuroinflammation in the central nervous system (CNS), driven largely by resident phagocytes, has been proposed as a significant contributor to disability accumulation in multiple sclerosis (MS) but has not been addressed therapeutically. Br
Externí odkaz:
https://doaj.org/article/7240258f9fe44a898fcf295ec6f91164
Autor:
Ross Gruber, Anna Blazier, Lan Lee, Sean Ryan, Agnes Cheong, Evis Havari, Timothy Turner, Dimitry Ofengeim
Publikováno v:
Sunday, April 23.
Autor:
Nora Rӧsch, Christian Barro, Zuzanna Michalak, Jens Kuhle, Carina Kaiser, Colin Mitchell, Aleksandra Maceski, Maria Pia Sormani, Jean Godin, Ludwig Kappos, David Leppert, Luke Chung, Alan Jacobs, Srinivas Shankara, Pascal Benkert, Evis Havari, Nadia Daizadeh, Tarek A Samad
Publikováno v:
Multiple Sclerosis Journal. 28:573-582
Background: Alemtuzumab efficacy and safety was demonstrated in CARE-MS I and extension studies (CAMMS03409; TOPAZ). Objective: Evaluate serum neurofilament light chain (sNfL) in CARE-MS I patients and highly active disease (HAD) subgroup, over 7 and
Autor:
Johanne Kaplan, William M. Siders, Evis Havari, Tri-Hung Nguyen, Michael J. Turner, Srinivas Shankara, Bruce L. Roberts, Juanita Campos-Rivera
Publikováno v:
Immunology. 141:123-131
Alemtuzumab is a humanized monoclonal antibody specific for the CD52 protein present at high levels on the surface of B and T lymphocytes. In clinical trials, alemtuzumab has shown a clinical benefit superior to that of interferon-β in relapsing-rem
Autor:
Evis Havari, HuiJuan Lv, Roderick T. Bronson, Kai W. Wucherpfennig, Bruno Kyewski, Myra A. Lipes, Shannon J. Turley, Raju V. S. R. K. Gottumukkala, Anne L. Fletcher, Ross O. Smith, Sheena Pinto, Khadir Raddassi, Anthony Rosenzweig, Lizbeth Cornivelli, Takashi Matsui
Publikováno v:
Journal of Clinical Investigation. 121:1561-1573
Autoimmunity has long been linked to myocarditis and its sequela, dilated cardiomyopathy, the leading causes of heart failure in young patients. However, the underlying mechanisms are poorly defined, with most clinical investigations focused on humor
Autor:
Roderick T. Bronson, Myra A. Lipes, Jacqueline A. Taylor, Evis Havari, Kai W. Wucherpfennig, Marcia F. McInerney
Publikováno v:
The Journal of Immunology. 172:2651-2658
Genome-wide analyses have shown that the MHC class II region is the principal locus that confers susceptibility to a number of human autoimmune diseases. Due to the high degree of linkage disequilibrium across the MHC, it has been difficult to dissec
Autor:
Rebecca G. Bagley, Evis Havari, Stephen L. Madden, Rajashree McLaren, William Weber, Tri-Hung Nguyen, Timothy D. Connors, Johanne Kaplan, Bruce L. Roberts, Beverly A. Teicher, Prashant R. Nambiar, Srinivas Shankara
Publikováno v:
International Journal of Oncology
Overexpression of TMPRSS4, a cell surface-associated transmembrane serine protease, has been reported in pancreatic, colorectal and thyroid cancers, and has been implicated in tumor cell migration and metastasis. Few reports have investigated both TM
Autor:
Rajashree McLaren, Johanne Kaplan, Stephen L. Madden, Srinivas Shankara, Mindy Zhang, Yide Jiang, Evis Havari, Bruce L. Roberts, Tri-Hung Nguyen
Publikováno v:
Leukemialymphoma. 53(4)
The molecular changes induced by alemtuzumab following binding of CD52 on B tumor cells were investigated. Alemtuzumab alone had no detectable impact on cell signaling but cross-linking of alemtuzumab on the surface of B tumor lines with anti-human F
Autor:
Bruce L. Roberts, Lamya S. Shihabuddin, Evis Havari, Johanne Kaplan, Christopher M. Treleaven, Michael J. Turner, William M. Siders, James Dodge
Publikováno v:
Journal of Neuroimmunology. 275:62-63
Autor:
Ana-Maria Lennon-Duménil, Marcia F. McInerney, Jacqueline A. Taylor, Devon Neely, Kai W. Wucherpfennig, Myra A. Lipes, Ludger Klein, Evis Havari
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 173(2)
Although HLA-DQ8 has been implicated as a key determinant of genetic susceptibility to human type 1 diabetes, spontaneous diabetes has been observed in HLA-DQ8 transgenic mice that lack expression of murine MHC class II molecules (mII−/−) only wh